Artivion (AORT) Revenue & Revenue Breakdown

Overview ForecastFinancials Chart Transcripts

Artivion Revenue Highlights

Latest Revenue (Y)

$441.33M

Latest Revenue (Q)

$113.39M

Main Segment (Y)

Aortic Stent Grafts

Main Geography (Y)

North America Segment

Artivion Revenue by Period

Artivion Revenue by Year

Date	Revenue	Change
2025-12-31	$441.33M	13.59%
2024-12-31	$388.54M	9.75%
2023-12-31	$354.00M	12.82%
2022-12-31	$313.79M	5.00%
2021-12-31	$298.84M	18.01%
2020-12-31	$253.23M	-8.32%
2019-12-31	$276.22M	5.09%
2018-12-31	$262.84M	38.55%
2017-12-31	$189.70M	5.17%
2016-12-31	$180.38M	23.63%
2015-12-31	$145.90M	0.87%
2014-12-31	$144.64M	2.75%
2013-12-31	$140.76M	6.87%
2012-12-31	$131.72M	10.11%
2011-12-31	$119.63M	2.56%
2010-12-31	$116.64M	4.44%
2009-12-31	$111.69M	6.31%
2008-12-31	$105.06M	10.87%
2007-12-31	$94.76M	16.54%
2006-12-31	$81.31M	17.36%
2005-12-31	$69.28M	11.06%
2004-12-31	$62.38M	4.79%
2003-12-31	$59.53M	-23.48%
2002-12-31	$77.80M	-11.26%
2001-12-31	$87.67M	13.72%
2000-12-31	$77.10M	15.55%
1999-12-31	$66.72M	9.92%
1998-12-31	$60.70M	19.25%
1997-12-31	$50.90M	37.57%
1996-12-31	$37.00M	27.59%
1995-12-31	$29.00M	22.88%
1994-12-31	$23.60M	11.32%
1993-12-31	$21.20M	-

Artivion generated $441.33M in revenue during NA 2025, up 13.59% compared to the previous quarter, and up 174.28% compared to the same period a year ago.

Artivion Revenue by Quarter

Date	Revenue	Change
2025-09-30	$113.39M	0.37%
2025-06-30	$112.97M	14.14%
2025-03-31	$98.98M	1.72%
2024-12-31	$97.31M	1.60%
2024-09-30	$95.78M	-2.29%
2024-06-30	$98.02M	0.60%
2024-03-31	$97.43M	4.02%
2023-12-31	$93.67M	6.62%
2023-09-30	$87.85M	-1.57%
2023-06-30	$89.25M	7.24%
2023-03-31	$83.23M	4.83%
2022-12-31	$79.40M	3.33%
2022-09-30	$76.84M	-4.36%
2022-06-30	$80.34M	4.05%
2022-03-31	$77.21M	-2.75%
2021-12-31	$79.39M	9.95%
2021-09-30	$72.21M	-5.18%
2021-06-30	$76.15M	7.12%
2021-03-31	$71.09M	4.70%
2020-12-31	$67.90M	4.25%
2020-09-30	$65.13M	21.13%
2020-06-30	$53.77M	-19.05%
2020-03-31	$66.43M	-4.69%
2019-12-31	$69.70M	2.68%
2019-09-30	$67.88M	-4.58%
2019-06-30	$71.14M	5.38%
2019-03-31	$67.50M	-0.43%
2018-12-31	$67.80M	4.96%
2018-09-30	$64.60M	-5.69%
2018-06-30	$68.50M	10.57%
2018-03-31	$61.95M	17.27%
2017-12-31	$52.83M	20.06%
2017-09-30	$44.00M	-7.99%
2017-06-30	$47.82M	6.12%
2017-03-31	$45.06M	0.07%
2016-12-31	$45.03M	-0.49%
2016-09-30	$45.25M	-3.89%
2016-06-30	$47.08M	9.45%
2016-03-31	$43.02M	7.98%
2015-12-31	$39.84M	8.54%
2015-09-30	$36.70M	3.31%
2015-06-30	$35.53M	5.01%
2015-03-31	$33.83M	-8.94%
2014-12-31	$37.15M	0.22%
2014-09-30	$37.07M	6.86%
2014-06-30	$34.69M	-2.91%
2014-03-31	$35.73M	0.77%
2013-12-31	$35.46M	-2.19%
2013-09-30	$36.25M	8.14%
2013-06-30	$33.52M	-5.67%
2013-03-31	$35.54M	8.34%
2012-12-31	$32.80M	-1.88%
2012-09-30	$33.43M	0.73%
2012-06-30	$33.19M	2.75%
2012-03-31	$32.30M	6.26%
2011-12-31	$30.40M	2.51%
2011-09-30	$29.65M	0.94%
2011-06-30	$29.38M	-2.71%
2011-03-31	$30.20M	3.33%
2010-12-31	$29.22M	2.74%
2010-09-30	$28.44M	-2.80%
2010-06-30	$29.26M	-1.53%
2010-03-31	$29.72M	3.85%
2009-12-31	$28.61M	1.40%
2009-09-30	$28.22M	0.20%
2009-06-30	$28.16M	5.53%
2009-03-31	$26.69M	4.53%
2008-12-31	$25.53M	-4.75%
2008-09-30	$26.80M	-1.29%
2008-06-30	$27.16M	6.21%
2008-03-31	$25.57M	1.99%
2007-12-31	$25.07M	-

Artivion generated $113.39M in revenue during Q3 2025, up 0.37% compared to the previous quarter, and up 115.68% compared to the same period a year ago.

Artivion Revenue Breakdown

Artivion Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
On X	$101.74M	$83.98M	$74.53M	$63.90M	$57.36M
Aortic Stent Grafts	$159.37M	$123.08M	$107.47M	-	-
Other Products	$8.11M	$9.27M	$11.17M	$8.32M	$8.13M
Preservation Services	$95.50M	$98.31M	$83.44M	$77.24M	-
Surgical Sealants	$76.60M	$73.90M	$68.02M	$65.38M	$70.71M
Products	-	$290.23M	$261.19M	$230.35M	$221.60M
Aortic Stents And Stent Grafts	-	-	-	$92.75M	$85.39M

Artivion's latest annual revenue breakdown by segment (product or service), as of Dec 25: Aortic Stent Grafts (36.11%), On X (23.05%), Preservation Services (21.64%), Surgical Sealants (17.36%), and Other Products (1.84%).

Quarterly Revenue by Product

Product/Service	Dec 25	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20
Preservation Services	$49.80M	$25.53M	$17.39M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
On X	$54.59M	$25.57M	$21.57M	$42.82M	$21.48M	$19.68M	$20.18M	$18.74M	$17.95M	$17.66M	$16.46M	$16.25M	$14.37M	$14.02M	$14.73M	$13.10M	$13.67M	$12.07M	$10.12M	-
Aortic Stent Grafts	$82.93M	$39.84M	$36.60M	$62.34M	$28.64M	$32.10M	$27.44M	$25.52M	$28.36M	$26.15M	$19.67M	$23.83M	$25.51M	-	-	-	-	-	-	-
Surgical Sealants	$39.21M	$19.29M	$18.11M	$38.48M	$18.44M	$16.98M	$18.51M	$16.23M	$16.57M	$16.70M	$17.37M	$15.97M	$15.68M	$16.54M	$17.86M	$17.83M	-	-	-	-
Other Products	$2.85M	$2.74M	$2.52M	$4.23M	$2.69M	$2.35M	$3.01M	$3.25M	$3.13M	$1.78M	$1.74M	$2.88M	$1.98M	$1.65M	$2.42M	$2.22M	-	-	-	-
Products	-	$87.44M	$78.80M	$147.87M	$71.24M	$71.11M	$69.14M	$63.75M	$66.00M	$62.29M	$55.25M	$58.94M	$57.54M	$53.11M	$56.08M	$53.34M	$50.50M	-	-	-
Domestic Hospitals	-	-	-	-	-	-	-	-	-	-	$40.79M	-	-	-	-	-	-	-	-	-
International Hospitals	-	-	-	-	-	-	-	-	-	-	$25.30M	-	-	-	-	-	-	-	-	-
International Distributor	-	-	-	-	-	-	-	-	-	-	$12.92M	-	-	-	-	-	-	-	-	-
Cardiogenesis	-	-	-	-	-	-	-	-	-	-	$389.00K	-	-	-	-	-	-	-	-	-
Aortic Stents And Stent Grafts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$20.90M	$21.06M	$20.20M	-	-	-
Photofix	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.11M	$1.13M	$880.00K
Per Clot	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$801.00K	$724.00K	$497.00K
Neopatch	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$64.00K	$58.00K	-
Bioglue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$17.08M	$15.81M	$12.44M
Cardiac Tissue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$9.13M	$10.68M	$8.06M
Cardiogenesis Cardiac Laser Therapy	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$106.00K	$83.00K	$164.00K
Vascular Tissue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$8.20M	$9.29M	-
Jotec Ag	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$15.29M	$13.17M

Artivion's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Aortic Stent Grafts (36.15%), On X (23.80%), Preservation Services (21.71%), Surgical Sealants (17.09%), and Other Products (1.24%).

Artivion Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
North America Segment	$221.74M	$197.94M	-	-	-
Asia Pacific Segment	$44.25M	$37.20M	-	-	-
Europe, the Middle East, and Africa Segments	$151.37M	$131.52M	-	-	-
Latin America Segment	$23.97M	$21.88M	-	-	-
UNITED STATES	-	-	$179.49M	$161.11M	-
Non-US	-	-	$174.52M	$152.68M	-
Non Us	-	-	-	-	$147.69M
U	-	-	-	-	$151.15M

Artivion's latest annual revenue breakdown by geography, as of Dec 25: North America Segment (50.24%), Europe, the Middle East, and Africa Segments (34.30%), Asia Pacific Segment (10.03%), and Latin America Segment (5.43%).

Quarterly Revenue by Country

Country	Dec 25	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24
Europe, the Middle East, and Africa Segments	$75.61M	$38.71M	$37.05M	$67.51M	$30.42M	$33.59M
Asia Pacific Segment	$24.91M	$11.13M	$8.21M	$19.23M	$10.37M	$7.61M
North America Segment	$116.38M	$57.57M	$47.79M	$97.92M	$49.09M	$50.93M
Latin America Segment	$12.48M	$5.56M	$5.93M	$10.67M	$5.90M	$5.31M

Artivion's latest quarterly revenue breakdown by geography, as of Dec 25: North America Segment (50.74%), Europe, the Middle East, and Africa Segments (32.96%), Asia Pacific Segment (10.86%), and Latin America Segment (5.44%).

Artivion Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
ARDT	Ardent Health Partners	$5.97B	$1.58B
BKD	Brookdale Senior Living	$3.20B	$813.16M
ITGR	Integer	$1.85B	$467.69M
LFST	LifeStance Health Group	$1.42B	$363.81M
ADUS	Addus HomeCare	$1.42B	$362.30M
INSP	Inspire Medical Systems	$911.98M	$224.50M
AORT	Artivion	$441.33M	$113.39M
PRCT	PROCEPT BioRobotics	$308.05M	$83.33M
LQDA	Liquidia	$158.32M	$54.34M
SSII	SS Innovations	$42.48M	$12.83M
COGT	Cogent Biosciences	-	-

AORT Revenue FAQ

What is Artivion’s yearly revenue?

Artivion's yearly revenue for 2025 was $441.33M, representing an increase of 13.59% compared to 2024. The company's yearly revenue for 2024 was $388.54M, representing an increase of 9.75% compared to 2023. AORT's yearly revenue for 2023 was $354M, representing an increase of 12.82% compared to 2022.

What is Artivion’s quarterly revenue?

Artivion's quarterly revenue for Q3 2025 was $113.39M, a 0.37% increase from the previous quarter (Q2 2025), and a 18.39% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $112.97M, a 14.14% increase from the previous quarter (Q1 2025), and a 15.26% increase year-over-year (Q2 2024). AORT's quarterly revenue for Q1 2025 was $98.98M, a 1.72% increase from the previous quarter (Q4 2024), and a 1.59% increase year-over-year (Q1 2024).

What is Artivion’s revenue growth rate?

Artivion's revenue growth rate for the last 3 years (2023-2025) was 24.67%, and for the last 5 years (2021-2025) was 47.68%.

What are Artivion’s revenue streams?

Artivion's revenue streams in c 25 are On X, Aortic Stent Grafts, Other Products, Preservation Services, and Surgical Sealants. On X generated $101.74M in revenue, accounting 23.05% of the company's total revenue, up 21.15% year-over-year. Aortic Stent Grafts generated $159.37M in revenue, accounting 36.11% of the company's total revenue, up 29.48% year-over-year. Other Products generated $8.11M in revenue, accounting 1.84% of the company's total revenue, down -12.48% year-over-year. Preservation Services generated $95.5M in revenue, accounting 21.64% of the company's total revenue, down -2.85% year-over-year. Surgical Sealants generated $76.6M in revenue, accounting 17.36% of the company's total revenue, up 3.66% year-over-year.

What is Artivion’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Artivion was Aortic Stent Grafts. This segment made a revenue of $159.37M, representing 36.11% of the company's total revenue.